Feb 24, 2022
MHWFAC research finds microneedle delivery successful in peanut test
A five-minute weekly dose of peanut protein through the skin, delivered by a novel microneedle technology, was superior in desensitizing peanut-allergic mice compared to administering the protein through a skin patch, a new study has found. Click for more details.
Jan 18, 2022
Moonlight Therapeutics completes pre-IND meeting with FDA
Moonlight Therapeutics, Inc., announced today it has completed a pre-Investigational New Drug Application (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss the regulatory pathway for the development of MOON101 for the treatment of peanut allergy. Click for more details.
Aug 2, 2021
Moonlight Therapeutics Awarded $1.9M Grant to Advance Development of Peanut Allergy Treatment
Moonlight Therapeutics, Inc., announced today funding from a Phase 2 Small Business grant from the National Institute of Allergy and Infectious Diseases (NIAID) to support the company’s preclinical development of a targeted peanut allergy treatment Click for more details.
May 11, 2020
Moonlight Therapeutics Secures Private Funding to Advance Development of Peanut Allergy Treatment
Moonlight Therapeutics, Inc., announced today an investment of over $300,000 from a small group of private investors. Moonlight Therapeutics is a biotechnology company developing treatments for food allergies and its lead program focuses on a treatment for peanut allergies. Click for more details.
May 7, 2019
National Institutes of Health Awards Moonlight Therapeutics with a $2.5 Million Grant to Advance Development of Peanut Allergy Treatment
Moonlight Therapeutics, Inc., a biotechnology company developing treatments for food allergies, announced today the receipt of $2.5 million in funding for preclinical studies and product development that will enable preparations for a clinical trial for its lead program in peanut allergy. This funding was awarded through a highly competitive Small Business Technology Transfer (STTR) Fast Track grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). Click for more details.
Jan 10, 2018
Moonlight Therapeutics presents at Biotech Showcase
Moonlight Therapeutics Inc will give a corporate presentation at Biotech Showcase 2018, an independent investor conference for public and private life sciences companies.
Moonlight Therapeutics joins ATDC Accelerate
The Advanced Technology Development Center (ATDC) at Georgia Tech is Georgia’s technology incubator. Founded in 1980, ATDC has developed a global reputation for fostering technological entrepreneurship. Forbes named ATDC to its list of “Incubators Changing the World” in 2010 and 2013, alongside Y Combinator and the Palo Alto Research Center.
Nov 15 2017
Moonlight Therapeutics presents at SEBio Investor Forum
Moonlight Therapeutics is selected to present at Southeast BIO (SEBIO) Investor Forum